Company & Sponsor Intelligence

Helse Stavanger HF

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting2

Completed1

Countries1

Therapeutic footprint

adhdalzheimers

Indexed studies

NCT06362707Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
alzheimers · NorwayPHASE2

NCT02754336Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study
adhd · NorwayNA

NCT06115200Norwegian Adult Mental Health Registry
adhd · NOT_YET_RECRUITING

Intelligence layer updated: 2026-11-03 06:12:30.767591+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →